Ingredient or product comparison
GHK-Cu Acne Scars Skin Regeneration Research: Comparison Analysis
| Treatment Approach | Mechanism of Action | Onset Timeline | Downtime Required | Skin Type Limitations | Research Evidence Base | Professional Assessment ||—|—|—|—|—|—|| GHK-Cu Peptide Application | Copper-dependent lysyl oxidase activation → organized collag
This source-based comparison does not add ratings or recommend a winner.
- | Treatment Approach | Mechanism of Action | Onset Timeline | Downtime Required | Skin Type Limitations | Research Evidence Base | Professional Assessment ||—|—|—|—|—|—|| GHK-Cu Peptide Application | Copper-dependent lysyl oxidase activation → organized collagen synthesis + MMP suppression | Measurable ECM changes 48–72 hours (in vitro); visible texture improvement 8–12 weeks (clinical observation) | None. No injury-based mechanism | None. Biochemical pathway works across all Fitzpatrick types | Robust in vitro data; limited large-scale RCTs in acne scar populations specifically | Best for atrophic scars requiring deep dermal remodeling without ablation; no PIH risk || Fractional CO₂ Laser | Controlled thermal injury → wound healing response with collagen neogenesis | Visible improvement 4–6 weeks post-treatment; full results 3–6 months | 5–7 days redness, peeling, crusting | High PIH risk in Fitzpatrick IV–VI; contraindicated in active acne | Extensive clinical trial data for moderate